Structure Therapeutics Inc. GPCR

Latest FY: 2025 Healthcare Biotechnology
Market Price $47.37
Market Cap $10.10B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025)
N/A
Full year reported
Net Income ↓-15.2% YoY
-$141.20M
Net Margin: N/A
Free Cash Flow ↓-91.5% YoY
-$225.81M
FCF Yield: -2.24%
EPS (Diluted) ↓-2.6% YoY
$-0.80
Basic: $-0.80
Return on Equity Efficiency
-9.3%
ROA: -8.9%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (GPCR)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2021
FY 2022 $-51.3M $-5.51 $-46.1M $-46.3M
FY 2023 $-89.6M -74.6% $-0.81 +85.3% 0.00% $-79.5M $-81.7M -76.5%
FY 2024 $-122.5M -36.7% $-0.78 +3.7% 0.00% $-116.6M $-117.9M -44.4%
FY 2025 $-141.2M -15.2% $-0.80 -2.6% 0.00% $-222.2M $-225.8M -91.5%
$

Valuation

Market Price $47.37
Market Cap $10.10B
Enterprise Value $9.31B
P/E Ratio N/A
P/B Ratio 6.66
FCF Yield -2.24%
Dividend Yield 0.00%
Shares Outstanding 213,223,549
%

Profitability & Margins

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) -9.31%
Return on Assets (ROA) -8.91%
Asset Turnover 0.00x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio 24.81
Cash Ratio 12.64
Debt / Equity 0.007
Debt / Assets 0.006
Cash & Equivalents $799.62M
Total Debt $10.10M
Book Value / Share $7.11
💧

Cash Flow Efficiency

Operating Cash Flow -$222.20M
Capital Expenditures (CapEx) $3.61M
Free Cash Flow -$225.81M
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.80
EPS (Basic) $-0.80
Dividends / Share N/A
Book Value / Share $7.11
EPS YoY Growth -2.56%
🏛️

Balance Sheet (FY 2025)

Total Assets $1.58B
Total Liabilities $67.54M
Stockholders' Equity $1.52B
Current Assets $1.57B
Current Liabilities $63.28M